Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 85 to 85 of 85 entries
Sorted by: Best Match Show Resources per page
Eculizumab for antibody-mediated rejection in heart transplantation: A case-control study.

Clinical transplantation

Kittleson MM, Patel N, Chang DH, Kransdorf EP, Kobashigawa JA, Patel JK.
PMID: 34402096
Clin Transplant. 2021 Dec;35(12):e14454. doi: 10.1111/ctr.14454. Epub 2021 Sep 23.

Complement inhibition offers a novel treatment approach for antibody-mediated rejection (AMR). We examined patients with hemodynamic compromise AMR 2010-2020, comparing eight patients supplemented with eculizumab to 10 patients without; administration was at the treating physician's discretion. There were no...

Cite
Kittleson MM, Patel N, Chang DH, et al. Eculizumab for antibody-mediated rejection in heart transplantation: A case-control study. Clin Transplant. 2021;35(12):e14454doi: 10.1111/ctr.14454.
Kittleson, M. M., Patel, N., Chang, D. H., Kransdorf, E. P., Kobashigawa, J. A., & Patel, J. K. (2021). Eculizumab for antibody-mediated rejection in heart transplantation: A case-control study. Clinical transplantation, 35(12), e14454. https://doi.org/10.1111/ctr.14454
Kittleson, Michelle M, et al. "Eculizumab for antibody-mediated rejection in heart transplantation: A case-control study." Clinical transplantation vol. 35,12 (2021): e14454. doi: https://doi.org/10.1111/ctr.14454
Kittleson MM, Patel N, Chang DH, Kransdorf EP, Kobashigawa JA, Patel JK. Eculizumab for antibody-mediated rejection in heart transplantation: A case-control study. Clin Transplant. 2021 Dec;35(12):e14454. doi: 10.1111/ctr.14454. Epub 2021 Sep 23. PMID: 34402096.
Copy Download .nbib Format: NLM
Showing 85 to 85 of 85 entries